TITLE

Effects of EPHX1 and CYP3A4 polymorphisms on carbamazepine metabolism in epileptic patients

AUTHOR(S)
Caruso, Antonietta; Bellia, Chiara; Pivetti, Alessia; Agnello, Luisa; Bazza, Federica; Scazzone, Concetta; Bivona, Giulia; Sasso, Bruna Lo; Ciaccio, Marcello
PUB. DATE
April 2014
SOURCE
Pharmacogenomics & Personalized Medicine;2014, Vol. 7, p117
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The aim of this study was to investigate the effect of two genetic polymorphisms in the coding regions (exon 3 and exon 4) of the EPHX1 gene, ie, 337T.C and 416A.G, respectively, on the metabolism of carbamazepine (CBZ) 10,11-epoxide (the active metabolite of CBZ) by evaluating the variation in serum CBZ 10,11-epoxide levels 4 hours after administration of the drug. Moreover, we reported the genotype frequencies of the CYP3A4*22 (rs 35599367, C.T) variant and its influence on the metabolism of CBZ. Methods: The analysis was performed in 50 patients receiving CBZ as monotherapy. DNA was extracted from leukocytes using a commercially available kit. Serum CBZ 10,11-epoxide levels were measured by high-performance liquid chromatography. Allelic discrimination was performed using polymerase chain reaction-restriction fragment length polymorphism. Statistical analysis of the difference in mean values for CBZ 10,11-epoxide levels according to genotype was performed using the Student's t-test with Statistical Package for the Social Sciences version 13 software. Results: Fourteen percent of the study group were CC, 42% were CT, and 44% were TT for the EPHX1 337T.C variant. No GG homozygote was identified for the EPHX1 416A.G variant; 64% were AA and 36% were AG. When we compared serum CBZ 10,11-epoxide levels 4 hours after drug administration, we found no statistically significant difference between the 337 CC, CT, and TT genotypes. Similarly, no difference in serum CBZ 10,11-epoxide levels was found between 416A.G AA and AG. Genotype frequencies for the CYP3A4*22 (rs 35599367 C.T) allelic variant were 94% for CC and 6% for CT, with no statistically significant difference in serum CBZ 10,11-epoxide levels between these genotypes 4 hours after administration of the drug (2.6±1.3 μg/μL and 2.5±1.2 μg/μL, respectively). Conclusion: Although there is some evidence of involvement of these polymorphisms in enzyme activity in vitro, we found no interference with CBZ metabolism in vivo.
ACCESSION #
95896533

 

Related Articles

  • Novel CYP2C19 629c>a mutant gene detection in Japanese subjects and estimation of its effect on conformation. Kimura, Sayaka; Hasegawa, Setsuo; Kobayashi, Ai; Yamaguchi, Hiroki; Yohda, Masafumi; Kubota, Takahiro // Drug Discoveries & Therapeutics;Dec2010, Vol. 4 Issue 6, p412 

    Gene polymorphism is considered to be one of the causes of poor metabolism (PM), and approximately 20 mutants have been reported for CYP2C19 thus far. In our analysis of the CYP2C19*3 mutant gene, we detected new CYP2C19 SNPs by cross checking with different procedures. We confirmed a new c>a...

  • Linked polymorphisms upstream of exons 1 and 2 of the human cholecystokinin gene are not associated with schizophrenia or bipolar disorder. Bowen, T.; Norton, N.; Jacobsen, N.J.O.; Guy, C.; Daniels, J.K.; Sanders, R.D.; Cardno, A.G.; Jones, L.A.; Murphy, K.C.; McGuffin, P.; Craddock, N.; O'Donovan, M.C.; Owen, M.J. // Molecular Psychiatry;1998, Vol. 3 Issue 1, p67 

    The evidence for a significant genetic contribution to the functional psychoses (schizophrenia and bipolar disorder) is now well established. However, in both cases, the non-mendelian mode of inheritance has made the identification of susceptibility loci particularly challenging. The...

  • Pseudopharmacoresistance: Is Inadequate Dosing to Blame? Wilner, Andrew // Neurology Reviews;Feb2008, Vol. 16 Issue 2, p21 

    The article presents the study conducted by physician H. -J. Meencke and colleagues, which found a link between pseudopharmacoresistance in patients with epilepsy and inadequate dosage of antiepileptic drugs. The study revealed that higher doses of carbamazepine and valproic acid resulted in...

  • Cathepsin D exon 2 polymorphism associated with general intelligence in a healthy older population. Payton, A; Holland, F; Diggle, P; Rabbitt, P; Horan, M; Davidson, Y; Gibbons, L; Worthington, J; Ollier, W E R; Pendleton, N // Molecular Psychiatry;2003, Vol. 8 Issue 1, p14 

    General intelligence is a heritable trait that is a risk factor for both the onset of dementia and the rate of cognitive decline in community-dwelling older persons. Previous studies screening for quantitative trait loci (QTLs) that influence general intelligence in healthy individuals have...

  • A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5. Suminaga, R.; Takeshima, Y.; Adachi, K.; Yagi, M.; Nakamura, H.; Matsuo, M. // Journal of Human Genetics;2002, Vol. 47 Issue 4, p196 

    The dystrophin gene, which is mutated in Duchenne muscular dystrophy, is the largest human gene. A full spectrum of the gene transcripts has not been fully elucidated yet, although two cryptic exons have so far been identified in the 5′ region of the dystrophin gene. Here, a novel...

  • Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Horiuchi, T; Tsukamoto, H; Morita, C; Sawabe, T; Harashima, S; Nakashima, H; Miyahara, H; Hashimura, C; Kondo, M // Genes & Immunity;Oct2000, Vol. 1 Issue 7, p464 

    Mannose binding lectin (MBL) deficiency may be associated with increased susceptibility to infection and autoimmune disorders, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). In the present study, we performed for the first systematic search for mutations in all the...

  • Myeloperoxidase gene sequence variations are associated with low-density-lipoprotein characteristics. Dolley, Guillaume; Lamarche, Benoit; Despr&és, Jean-Pierre; Bouchard, Claude; Pérusse, Louis; Vohl, Marie-Claude // Journal of Human Genetics;May2008, Vol. 53 Issue 5, p439 

    The small, dense low-density-lipoprotein (LDL) phenotype is associated with an increased atherosclerosis risk. A genome-wide scan performed on 236 nuclear families of the Quebec Family Study (QFS) revealed a quantitative trait locus (QTL) for LDL peak-particle size (LDL-PPD) on the 17q21 region....

  • Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary history. Sabbagh, Audrey; Langaney, André; Darlu, Pierre; Gérard, Nathalie; Krishnamoorthy, Rajagopal; Poloni, Estella S. // BMC Genetics;2008, Vol. 9, Special section p1 

    Background: The N-acetyltransferase 2 (NAT2) gene plays a crucial role in the metabolism of many drugs and xenobiotics. As it represents a likely target of population-specific selection pressures, we fully sequenced the NAT2 coding region in 97 Mandenka individuals from Senegal, and compared...

  • Identification of novel single nucleotide polymorphisms in intron 1B and exon 1C of the human interleukin-1 receptor type I (IL-1RI) gene. Sitara, D; Olomolaiye, O; Wood, N; Keen, L; Morse, H; Elson, C; Westacott, C; Bidwell, J // Genes & Immunity;Nov99, Vol. 1 Issue 2, p161 

    We have identified two novel single nucleotide polymorphisms in the 5' region of the human IL-1RI gene: (1) A&rarr G at position 52 in intron 1B (GenBank accession number AF146426), which creates an Mspl restriction endonuclease site. Allele frequencies in a Caucasian population were 0.1 (A...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics